NCT04892212 Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis Status UNKNOWN Phase PHASE2/PHASE3
NCT04883619 A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis Status WITHDRAWN Phase PHASE2
NCT04870359 Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation Status COMPLETED Phase NA
NCT04702256 Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF Status RECRUITING Phase PHASE3
NCT04645589 Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis Status COMPLETED Phase N/A
NCT04643470 Zanubrutinib in Participants With Active Proliferative Lupus Nephritis Status COMPLETED Phase PHASE2
NCT04564339 Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) Status TERMINATED Phase PHASE2
NCT04534647 Serological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 Cohort Status UNKNOWN Phase N/A
NCT04522505 Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis Status COMPLETED Phase N/A
NCT04449991 Per-protocol Repeat Kidney Biopsy in Incident Cases of Lupus Nephritis Status RECRUITING Phase NA
NCT04376827 A Study of Guselkumab in Participants With Active Lupus Nephritis Status TERMINATED Phase PHASE2
NCT04318600 Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis Status COMPLETED Phase PHASE1
NCT04266860 Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients Status COMPLETED Phase NA
NCT04221477 A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04218890 TF, TFPI and Plasmin as Novel Bio-markers in Early Diagnosis of Lupus Nephritis Status UNKNOWN Phase N/A